Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancerKenichi Sugihara, Toshiaki Watanabe, Kei Muro et al.|International Journal of Clinical Oncology|2017Cited by 2.5k
Randomized Phase III Study of Gemcitabine Plus S-1, S-1 Alone, or Gemcitabine Alone in Patients With Locally Advanced and Metastatic Pancreatic Cancer in Japan and Taiwan: GEST StudyHideki Ueno, Masao Tanaka, Tatsuya Ioka et al.|Journal of Clinical Oncology|2013Cited by 632
Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancerToshiaki Watanabe, Michio Itabashi, Yasuhiro Shimada et al.|International Journal of Clinical Oncology|2015Cited by 600
Olaparib in combination with paclitaxel in patients with advanced gastric cancer who have progressed following first-line therapy (GOLD): a double-blind, randomised, placebo-controlled, phase 3 trialYung‐Jue Bang, Narikazu Boku, Rui‐Hua Xu et al.|The Lancet Oncology|2017Cited by 291
Multicenter retrospective analysis of systemic chemotherapy for advanced neuroendocrine carcinoma of the digestive systemTomohiro Yamaguchi, Takuji Okusaka, Nozomu Machida et al.|Cancer Science|2014Cited by 238